Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA first to approve Darzalex for multiple myeloma

Nov. 17, 2015

Researchers present long-term survival data on AVX-701 cancer vaccine

Nov. 17, 2015

Early clinical data for Macrogenics' MGA-271

Nov. 16, 2015

Daratumumab granted U.S. orphan status for diffuse large B-cell lymphoma

Nov. 16, 2015

Vadastuximab talirine from Seattle Genetics obtains FDA orphan drug designation

Nov. 13, 2015

Stanford University reports development of anti-CD99 MAbs

Nov. 12, 2015

New phase II trial investigates combination of CMB-305 and atezolizumab for soft tissue sarcoma

Nov. 12, 2015

Squamous NSCLC response rate improved when necitumumab added to paclitaxel-carboplatin

Nov. 10, 2015

Phase I findings for Bavarian Nordic's MVA-BN Brachyury cancer vaccine

Nov. 6, 2015

BriaCell receives FDA approval to begin phase I/IIa trial of BriaVax

Nov. 5, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...